简体中文

Who We Are

BeyondSpring is a Global, Clinical-Stage
Bio-pharmaceutical Company

Developing Innovative Immuno-Oncology Cancer Therapies with a Robust Pipeline from Internal Development and from Collaboration with University of Washington in De Novo Drug Discovery Using a Ubiquitination Platform.

Detail



Development

Pipeline

We have a robust drug development pipeline at various clinical and pre-clinical stages.

Read More
NewsMedia

© BeyondSpring Inc. All Rights Reserved.